Sanofi should hear from the FDA in September about its application for Sarclisa as a first-line therapy for multiple myeloma after the US regulator gave it a priority review. The French pharma group ...
According to a superseding indictment unsealed in January 2024 by the U.S. Attorney's Office for the Eastern District of New ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results